Cardinal Health (CAH) Tops Q1 EPS by 28c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Leerink Partners Raises Price Target on Cardinal Health (CAH) Following Conference Call
November 4, 2015 3:03 PM ESTLeerink Partners reiterated an Outperform rating on Cardinal Health (NYSE: CAH), and raised the price target to $105.00 (from $100.00), following the company's 1Q16 earnings conference call. The strong 49bp increase in pharmaceutical segment operating margin (to 2.61%) was driven by generic strength. F2016 pharmaceutical segment revenue is now expected to be in the... More
UBS Raises Price target on Cardinal Health (CAH) Following 1Q16 Conference Call
November 3, 2015 8:36 AM ESTUBS reiterated a Buy rating on Cardinal Health (NYSE: CAH), and raise the price target to $100.00 (from $97.00), following 1Q16 earnings call. On CAH's F1Q16 earnings call, the company provided some fresh input on the outlook for both brand and generic pricing. Regarding brand drug inflation, the rate in F1Q16 was slightly higher than the prior... More



